Ke Li

EGFR-TKI resistance promotes immune escape in lung cancer via increased PD-L1 expression

Shunli Peng, Rong Wang, Xiaojuan Zhang et al. · Molecular Cancer · 2019 · 295 citations · Full text

Untargeted metabolomics identifies succinate as a biomarker and therapeutic target in aortic aneurysm and dissection

Hongtu Cui, Yanghui Chen, Ke Li et al. · European Heart Journal · 2021 · 146 citations · Full text

A Phase I study of safety and pharmacokinetics of fruquintinib, a novel selective inhibitor of vascular endothelial growth factor receptor-1, -2, and -3 tyrosine kinases in Chinese patients with advanced solid tumors

Junning Cao, Jian Zhang, Wei Peng et al. · Cancer Chemotherapy and Pharmacology · 2016 · 70 citations

Angiogenesis, Glioma, Medicine +9

Immuno-PET imaging of 68Ga-labeled nanobody Nb109 for dynamic monitoring the PD-L1 expression in cancers

Qingzhu Liu, Lei Jiang, Ke Li et al. · Cancer Immunology Immunotherapy · 2021 · 67 citations · Full text

Positron Emission Tomography, Engineering, Immuno-pet Imaging +12

A biotin receptor-targeted silicon(IV) phthalocyanine for in vivo tumor imaging and photodynamic therapy

Ke Li, Wenyi Dong, Qingzhu Liu et al. · Journal of Photochemistry and Photobiology B Biology · 2018 · 64 citations

Engineering, Photochemistry, Photodynamic Therapy +10